Invicro
  • News: Guidelines by FDA for Clinical Trial Imaging

    (May 2018) – FDA recently published new guidelines for imaging endpoints in clinical trials. Invicro’s late-phase clinical operations team are experts in supporting clinical studies which depend upon imaging-based endpoints, in particular those in the oncology, CNS, musculoskeletal, and GI therapeutic areas.
    SEE MORE

  • News: Invicro Hires Peter Genakos as New Haven’s General Manager

    Boston, MA (April 20, 2018) – Invicro, LLC, a Konica Minolta company and a leading provider of imaging services and software for research and drug development, today announced the appointment of Mr. Peter Genakos, J.D. as General Manager of the New Haven, CT office.
    SEE MORE

  • News: Invicro Launches AmyloidIQ to Advance Clinical Imaging Trials in Alzheimer’s Disease

    Boston, MA (March 19,  2018) – Invicro LLC, a Konica Minolta company and a leading provider of imaging services and software for research and drug development, recently announced the launch of AmyloidIQ, a new and advanced algorithm that quantifies Amyloid scans for use in subject stratification and clinical trials of Alzheimer’s disease therapies. SEE MORE

  • News: Invicro Hires Edward Hogan as Senior Vice President of Clinical Operations

    Boston, MA (February 27,  2018) – Invicro, LLC, a Konica Minolta company and a leading provider of imaging services and software for research and drug development, today announced the hiring of Mr. Edward Hogan, M.S. as Senior Vice President of Clinical Operations. SEE MORE

  • News: Invicro Appoints George Abe as Senior Vice President, Pathology

    Boston, MA (February 20,  2018) – Invicro LLC, a Konica Minolta company and a leading provider of imaging services and software for research and drug development, today announced the hiring of Mr. George Abe, as Senior Vice President of Pathology. SEE MORE

  • News: Ambry Genetics and Invicro Announce Partnership to Provide Enhanced Capabilities with Advanced Genomics Services to Enable Precision Medicine

    Aliso Viejo, CA (January 31,  2018) – Partnership provides Pharmaceutical Companies a more Comprehensive Solution in an Effort to Improve Patient Care. SEE MORE

  • News: Boston-Based Invicro Further Expands Imaging Capabilities with Acquisition of Core Clinical, Inc.

    BOSTON, MA (October 26, 2017) – Invicro, LLC, a leading provider of imaging services and software for research and drug development, announced today that it has completed the acquisition of Core Clinical, Inc., a medical imaging core lab based in Bucks County, PA. SEE MORE

  • News: Konica Minolta Accelerates Expansion of Precision Medicine Business Through Acquisition of US-based Pharmaceutical Research Company, Invicro

    BOSTON, MA (September 25, 2017) –  Through molecular digital imaging technology, acquisition offers new value for drug discovery and development focused on the fields of immuno-oncology and neurodegenerative disease SEE MORE

  • News: Invicro Acquires Imanova

    BOSTON, MA (September 12, 2017) –  Invicro, a leading provider of imaging services and software for research and drug development, announced today the acquisition of Imanova UK-based Imanova. Invicro and Imanova will merge all activities to establish the world’s largest provider of translational imaging services and analytics from pre-clinical development through to late-phase clinical trials. SEE MORE

  • Events: 2017 Invicro Software User Meeting

    BOSTON, MA (August 19, 2017) –  Click here to register for this event.

  • Events: Invicro at WMIC 2017

    BOSTON, MA (August 19, 2017) –  Visit our team at booth 403.  SEE MORE

  • News: Bioverativ and Invicro Form Novel, Advanced Imaging Collaboration

    WALTHAM, Mass. & BOSTON, Mass – August 24, 2017 – Bioverativ Inc. (NASDAQ: BIVV), a global biotechnology company focused on the discovery, development and commercialization of innovative therapies for hemophilia and other rare blood disorders, and Invicro, LLC, a leading provider of imaging services and analysis for pharmaceutical research and development, today announced that they have formed a strategic collaboration focused on expanding the use and adoption of leading imaging technologies, including ultrasound and radiolabeled imaging, to improve the diagnosis and management of joint disease in people with hemophilia. SEE MORE

  • Events: Invicro at SNMMI 2017

    BOSTON, MA (June 3, 2017) –  Visit our team at booth 775.  SEE MORE

  • Events: Invicro at Bio-IT World 2017

    BOSTON, MA (May 8, 2017) –  Visit our team at booth #528, and join us for beer and wine at our booth from 5:30 – 6:30PM on Wednesday, May 24!

Archived News

      Contact the Author:

      Amanda Harrell | T. +1 215-644-3409 | E. aharrell@invicro.com